增强抗瘤免疫力,使用具有刺激反应的半孔与化疗和光热疗法结合使用
Shuai Chen1, Rui Huang2,3, Feiyang Shen2,3
1Institute of Translational Medicine, National Facility for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
Biomaterials science
|May 17, 2024
概括
这项研究引入了一种新的纳米粒子 (DOX/MSN-4S@PDA-HA),它结合化疗和光热疗法来激活抗瘤免疫力,并有效抑制瘤生长和转移.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 化疗因免疫抑制性瘤微环境 (TME) 和全身毒性而面临挑战.
- 光热疗法 (PTT) 可以通过释放瘤新抗原来激活抗瘤免疫力.
- 制定提高化疗疗效和减少副作用的策略至关重要.
研究的目的:
- 设计和评估一种用于联合化疗和光热疗法的新型纳米粒子系统.
- 研究纳米粒子激活抗瘤免疫力和克服TME的能力.
- 评估纳米粒子in vivo和in vitro的治疗疗效和有针对性的输送.
主要方法:
- 合成带有四素结合的半孔纳米颗粒 (MSN),载有多克索鲁比 (DOX) 并涂有多多巴胺 (PDA) 和酸 (HA).
- 评估药物释放动力学,H2S生成,酸/NIR触发性质和CD44向的输送.
- 评估体内和体外抗瘤疗效,包括TME调制,免疫细胞死亡 (ICD) 诱导和转移抑制.
主要成果:
- DOX/MSN-4S@PDA-HA纳米颗粒通过GSH敏感的四素化键和H2S生成证明了受控的DOX释放.
- 在NIR照射下,PDA涂层提供了酸敏感性和温和的光热特性.
- 实现了针对CD44表达瘤细胞的向输送,增强了药物积累并减少了全身毒性.
- 活体研究显示免疫抑制性TME的逆转,强烈的ICD诱导,显著的瘤生长抑制和抑制肺和肝转移.
结论:
- DOX/MSN-4S@PDA-HA纳米粒子提供了一个有前途的协同作用的化学光热疗法方法.
- 该系统有效地激活了抗瘤免疫力,并克服了免疫抑制的TME.
- 这种纳米颗粒配方表现出受控的药物释放,良好的生物相容性和显著的抗瘤能力,需要进一步研究癌症治疗.
相关概念视频
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


